Pharmacological investigations with benzoctamine (Tacitin), a new psycho-active agent.
D000759:Adjuvants, Anesthesia; D000374:Aggression / Q000187:drug effects; D000818:Animals; D000873:Anthracenes / Q000494:pharmacology* / Q000633:toxicity; D002415:Cats; D002490:Central Nervous System / Q000187:drug effects*; D002707:Chlordiazepoxide / Q000494:pharmacology; D002746:Chlorpromazine / Q000494:pharmacology; D003891:Desipramine / Q000494:pharmacology; D003975:Diazepam / Q000494:pharmacology; D004285:Dogs; D000882:Haplorhini; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D007099:Imipramine / Q000494:pharmacology; D051379:Mice; D009046:Motor Neurons / Q000187:drug effects; D009119:Muscle Contraction / Q000187:drug effects; D011817:Rabbits; D051381:Rats; D012018:Reflex / Q000187:drug effects; D012119:Respiration / Q000187:drug effects; D012640:Seizures / Q000188:drug therapy
D000759:Adjuvants, Anesthesia; D000873:Anthracenes; D002707:Chlordiazepoxide; D007099:Imipramine; D003975:Diazepam; D003891:Desipramine; D002746:Chlorpromazine